Hak Choy

16.9k citations
198 papers · 10.2k · 5 hit papers · h-index 52

Impact in

    • Lung Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Brain Metastases and Treatment
    • Radiation Therapy and Dosimetry
  • Radiation top 0.2%
    • Advanced Radiotherapy Techniques

Papers in

    • Lung Cancer Diagnosis and Treatment 68
    • Lung Cancer Treatments and Mutations 63
    • Brain Metastases and Treatment 11
    • Lung Cancer Research Studies 33
    • Cancer Treatment and Pharmacology 18

Hak Choy

197 papers receiving 9.9k citations

Hak Choy's Hit Papers

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer 2019 · 378 citations
3780+3+7Years since publication200400600

Peers

Hak Choy
Comparison fields: 5 of 148
  • Pulmonary and Respiratory Medicine 5.4k
  • Radiation 1.4k
  • Oncology 2.9k
  • Radiology, Nuclear Medicine and Imaging 1.3k
  • Otorhinolaryngology 222
Replace Bin S. Teh with:
Bin S. Teh United States
Feng‐Ming Kong United States
Corinne Faivre‐Finn United Kingdom
Guy Storme Belgium
Andrew T. Turrisi United States
Dirk De Ruysscher Netherlands
Joe Y. Chang United States
Daniel T. Chang United States
Dirk De Ruysscher Netherlands
Vincent Khoo United Kingdom
Hak Choy relative to Bin S. Teh United States Bin S. Teh's profile →
Citations per field
00.5×1.5×2.2×
Bin S. Teh · 1×
Citations per year

Countries citing papers authored by Hak Choy

Since Specialization
Citations

This map shows the geographic impact of Hak Choy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hak Choy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hak Choy more than expected).

Fields of papers citing papers by Hak Choy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hak Choy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hak Choy. The network helps show where Hak Choy may publish in the future.

Co-authors

The 25 scholars most cited alongside Hak Choy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hak Choy Line = papers co-authored together Hak Choy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
Hit paper breakdown →
2017690
2
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Hit paper breakdown →
2016557
3
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer
Hit paper breakdown →
2019378
4 2005346
5
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
Hit paper breakdown →
2015311
6 2010279
7 2010274
8
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer
Hit paper breakdown →
2018262
9 2013241
10 2010220
11 2014218
12 2010202
13 1993197
14 2018189
15 2008185
16 2018171
17
A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
2001163
18 2014159
19 1995157
20 2003152

About Hak Choy

Hak Choy is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Radiation and Molecular Biology, having authored 198 papers that have together received 10.2k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (68 papers), Lung Cancer Treatments and Mutations (63 papers), Lung Cancer Research Studies (33 papers), Advanced Radiotherapy Techniques (27 papers), Cancer Treatment and Pharmacology (18 papers), Inflammatory mediators and NSAID effects (13 papers), Cancer therapeutics and mechanisms (13 papers) and Brain Metastases and Treatment (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.4k citations), Radiation (1.4k citations), Oncology (2.9k citations), Radiology, Nuclear Medicine and Imaging (1.3k citations) and Otorhinolaryngology (222 citations). Hak Choy has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Robert Timmerman, Puneeth Iyengar, Walter J. Curran, Rebecca Paulus, Steven E. Schild, Elizabeth Gore, Chen Hu, Ritsuko Komaki, Maria Werner‐Wasik and Kenneth D. Westover. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Lung Cancer and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact